JUL 29, 2019 7:57 AM PDT

Medications Used for Atrial fibrillation May Increase Falls

WRITTEN BY: Nouran Amin

Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at a higher risk of falling with debilitating chronic conditions and being prescribed certain drugs.

For example, atrial fibrillation—a condition characterized by the rapid contraction in one region of the heart—is most common among adults over 65 and is one of the major contributors to falling and fainting.

Learn more about atrial fibrillation:

Treatments for atrial fibrillation often include beta-blockers, certain calcium channel blockers (diltiazem, verapamil), and digoxin. Others drugs may also include amiodarone, flecainide, and propafenone. Unfortunately, these treatments increase the risk of falling among older adults but the connection to how this happens has not been studied until now

In a publication in the Journal of the American Geriatrics Society, researchers used data generated from Danish health records of atrial fibrillation patients between 65 and 100 years who were prescribed treatments. The researchers then examined those patients who had hospital admissions for falls or fainting and who suffered fall-related injuries such as varying degrees of head injuries or a fractured thigh, elbow, forearm, wrist, shoulder or upper arm, pelvis, and skull.

Results showed that patients who took amiodarone were at a significant risk of falling whether on short-term or long-term treatment and the medication digoxin held a slight association with fall-related injuries. In addition, treatments taken within the first 90 days, particularly the first two weeks, contributed to an even higher risk of injury.

"Our findings add evidence that, for older patients with atrial fibrillation, treatment with amiodarone is associated with a higher risk of fall-related injuries and fainting," stated the researchers.

Overall, the findings conclude the critical importance of health care providers weighing the pros and cons of reporting atrial fibrillation treatments to patients and the potential risk it may cause regarding their safety and patient care.

Source: Health in Aging

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 13, 2020
Drug Discovery & Development
JAN 13, 2020
Vaccine Against Alzheimer's to Hit Clinical Trials
Currently Alzheimer’s disease is thought to affect around 50 million people around the world, with this figure doubling every year. Currently with no...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
JAN 20, 2020
Cancer
JAN 20, 2020
Did you know these non-cancer drugs can also fight cancer?
A study from MIT. Harvard and the Dana-Farber Cancer Institute has concluded that almost 50 existing non-oncological drugs have anti-cancer properties capa...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Frequent Cannabis Use Could Affect Driving Safety
A new study suggests that heavy marijuana users have the potential to be dangerous drivers. However, hazardous driving appears to be isolated to users who ...
FEB 24, 2020
Drug Discovery & Development
FEB 24, 2020
Leukemic Drugs May Target Lung Cancer
Two approved therapeutics for treating leukemia are currently being investigated for treatment-resistant lung cancer.  The findings were based on a li...
Loading Comments...